<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
12714-217-90
</NDCCode>
<PackageDescription>
90 mg in 1 SYRINGE (12714-217-90)
</PackageDescription>
<NDC11Code>
12714-0217-90
</NDC11Code>
<ProductNDC>
12714-217
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Risankizumbab
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20190423
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Boehringer Ingelheim Pharma GmbH and Co. KG
</LabelerName>
<SubstanceName>
RISANKIZUMAB
</SubstanceName>
<StrengthNumber>
90
</StrengthNumber>
<StrengthUnit>
mg/90mg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2024-05-23
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
23-APR-19
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>